Pharmacogenomics an introduction and clinical perspective /
Pharmacogenomics an introduction and clinical perspective / [electronic resource] :
edited by Joseph S. Bertino Jr, C. Lindsay DeVane, Uwe Fuhr, Angela D. M. Kashuba, Joseph D. Ma.
- 1st ed.
- New York, N.Y. : McGraw-Hill Education LLC., c2013.
- xiii, 274 p. : ill., figs., tables.
- McGraw-Hill's AccessPharmacy A Lange medical book .
- McGraw-Hill's AccessPharmacy. A Lange medical book. .
"A Lange medical book."
Includes bibliographical references and indexes.
Section I. General Concepts -- CHAPTER 1. Developing Perspectives on Pharmacogenomics -- CHAPTER 2. Genetic Concepts of Pharmacogenomics: Basic Review of DNA, Genes, Polymorphisms, Haplotypes and Nomenclature -- CHAPTER 3. Analytical Methods to Identify Genetic Variations and Bioinformatics -- CHAPTER 4. Regulatory Considerations in Pharmacogenomics at EMA and US FDA -- CHAPTER 5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics -- CHAPTER 6A. Pharmacogenetics of Cytochrome P450 -- CHAPTER 6B. Phase II Drug-Metabolizing Enzymes -- CHAPTER 7. Drug Transporters -- CHAPTER 8. Nongenetic Influences on Drug Metabolism -- CHAPTER 9. Public Access to Pharmacogenomic Testing and Patient Counseling -- CHAPTER 10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing --Section II. Clinical Application of Pharmacogenomics -- CHAPTER 11. Cardiovascular Pharmacogenomics -- CHAPTER 12. Pharmacogenomics and Pharmacogenetics for Infectious Diseases -- CHAPTER 13. Pharmacogenomics in Oncology -- CHAPTER 14. Psychiatry and Addiction Medicine -- CHAPTER 15. Immunology, Transplantation, and Vaccines -- CHAPTER 16. Pharmacogenomics in Neurology -- CHAPTER 17A. Pharmacogenomics of Gastrointestinal Drugs: Focus on Proton Pump Inhibitors -- CHAPTER 17B. Genomics and the Kidney.
0071741690 (eISBN) 9780071741699 (e-ISBN) 9781283656160 (print-ISBN) 1283656167 (print-ISBN) 6613968668 9786613968661
2012024941
Pharmacogenomics --Textbooks.
Pharmacogenetics.
Pharmaceutical Preparations --metabolism.
Pharmacological Phenomena --genetics.
RM301.3.G45 / P43 2013
615.1/9
2012 I-854 QV 38.5 / P534 2013
"A Lange medical book."
Includes bibliographical references and indexes.
Section I. General Concepts -- CHAPTER 1. Developing Perspectives on Pharmacogenomics -- CHAPTER 2. Genetic Concepts of Pharmacogenomics: Basic Review of DNA, Genes, Polymorphisms, Haplotypes and Nomenclature -- CHAPTER 3. Analytical Methods to Identify Genetic Variations and Bioinformatics -- CHAPTER 4. Regulatory Considerations in Pharmacogenomics at EMA and US FDA -- CHAPTER 5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics -- CHAPTER 6A. Pharmacogenetics of Cytochrome P450 -- CHAPTER 6B. Phase II Drug-Metabolizing Enzymes -- CHAPTER 7. Drug Transporters -- CHAPTER 8. Nongenetic Influences on Drug Metabolism -- CHAPTER 9. Public Access to Pharmacogenomic Testing and Patient Counseling -- CHAPTER 10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing --Section II. Clinical Application of Pharmacogenomics -- CHAPTER 11. Cardiovascular Pharmacogenomics -- CHAPTER 12. Pharmacogenomics and Pharmacogenetics for Infectious Diseases -- CHAPTER 13. Pharmacogenomics in Oncology -- CHAPTER 14. Psychiatry and Addiction Medicine -- CHAPTER 15. Immunology, Transplantation, and Vaccines -- CHAPTER 16. Pharmacogenomics in Neurology -- CHAPTER 17A. Pharmacogenomics of Gastrointestinal Drugs: Focus on Proton Pump Inhibitors -- CHAPTER 17B. Genomics and the Kidney.
0071741690 (eISBN) 9780071741699 (e-ISBN) 9781283656160 (print-ISBN) 1283656167 (print-ISBN) 6613968668 9786613968661
2012024941
Pharmacogenomics --Textbooks.
Pharmacogenetics.
Pharmaceutical Preparations --metabolism.
Pharmacological Phenomena --genetics.
RM301.3.G45 / P43 2013
615.1/9
2012 I-854 QV 38.5 / P534 2013